Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used …

Long COVID (LC) is a condition in which patients do not fully recover from the initial SARS-
CoV-2 infection but rather have persistent or new symptoms for months to years following …

The mechanisms of postacute medical conditions and unexplained symptoms after SARS-
CoV-2 infection [Long Covid (LC)] are incompletely understood. There is growing evidence …

Given the global surge in autoimmune diseases, it is critical to evaluate emerging
therapeutic interventions. Despite numerous new targeted immunomodulatory therapies …

The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms
(Long COVID) following SARS-CoV-2 infection are incompletely understood. There is …

Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela
of SARS-CoV-2 infection,, yet the pathophysiological mechanism connecting the infection to …

Since the onset of the COVID-19 pandemic, significant progress has been made in
developing effective preventive and therapeutic strategies against severe acute SARS-CoV …

Long COVID is the name given to a syndrome comprising a wide variety of symptoms
persisting more than 3 months after acute benign COVID-19, with a prevalence ranging from …

The associations between longitudinal dynamics and the breadth of SARS‐CoV‐2
neutralizing antibody (nAb) response with various Long COVID phenotypes before …